Micropapillary urothelial carcinoma (MPUC) is a rare but an aggressive variant of urothelial
carcinoma. MPUC has been shown to commonly exhibit ERBB2 amplification and HER2 …

Comprehensive molecular analyses of urothelial bladder cancer (UBC) have defined distinct
subtypes with potential therapeutic implications. In this study, we focused on micropapillary …

Abstract Purpose of Review This review will discuss micropapillary urothelial carcinoma with
respect to biology, histopathologic characteristics, genetic and molecular features …

Micropapillary urothelial carcinoma exhibits amplification of the human epidermal growth
factor receptor, ERBB2 (HER2), and overexpression of the ERBB2 protein product. The …

In this report, we present the clinicopathologic features of 13 cases of the invasive
micropapillary variant of urothelial carcinoma. This is a rare and aggressive variant of …

Purpose: Micropapillary urothelial carcinoma (MPUC) is a rare and aggressive form of
bladder cancer. We conducted genomic analyses [next-generation sequencing (NGS)] of …

Aims: To investigate whether prognosis in micropapillary urothelial carcinoma is related to
the proportion of the micropapillary component (MPC), and to identify the …

Objectives Micropapillary urothelial carcinoma of the urinary bladder (MPUC) is a rare
variant of urothelial carcinoma which has aggressive clinical characteristics. The objective is …

Background Human epidermal growth factor receptor 2 (HER2) protein overexpression or
gene amplification has been shown in urothelial bladder cancer. This could be helpful when …

Human epidermal growth factor receptor-2 (HER2) is a well-recognized growth-promoting
factor in cancer, although its application to urothelial carcinoma has been limited because of …